Karuna Pharmaceuticals. Developing first in class agents that will improve the lives of those suffering from schizophrenia.
Karuna Pharmaceuticals is a drug development company advancing innovative treatments for schizophrenia. Karuna was co-founded by PureTech Ventures together with some of the world’s leading schizophrenia experts.
Schizophrenia is a devastating illness for both patients and their families. Karuna’s mission is to develop agents in order to dramatically improve the lives of people living with schizophrenia.
Karuṇā means “the desire to relieve others
of suffering” in Sanskrit.